Randomized, placebo-controlled trial of the anti-tumor necrosis factor antibody fragment afelimomab in hyperinflammatory response during severe sepsis: The RAMSES study
Konrad Reinhart*, Thilo Menges, Bengt Gardlund, Jan Harm Zwaveling, Mark Smithes, Jean Louis Vincent, Jose Maria Tellado, Antonio Salgado-Remigio, Reuven Zimlichman, Stuart Withington, Klaus Tschaikowsky, Rainer Brase, Pierre Damas, Hartmut Kupper, Joachim Kempeni, Juergen Eiselstein, Martin Kaul
Research output: Contribution to journal › Article › peer-review
218Scopus
citations
Fingerprint
Dive into the research topics of 'Randomized, placebo-controlled trial of the anti-tumor necrosis factor antibody fragment afelimomab in hyperinflammatory response during severe sepsis: The RAMSES study'. Together they form a unique fingerprint.